PharmaTher Announces FDA Approval of Ketamine IND In The
PharmaTher Announces FDA Approval of Ketamine IND In The Treatment of Parkinson’s Disease May 17, 2021 07:59 ET | Source: PharmaTher Holdings Ltd. PharmaTher Holdings Ltd. Vancouver, British Columbia, CANADA TORONTO, May 17, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a psychedelics biotech company, is pleased to announce that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s Investigational New Drug (“IND”) application to proceed with a Ph...
Source: globenewswire.com